Skip to Content
Merck

Optimization of a series of multi-isoform PI3 kinase inhibitors.

Bioorganic & medicinal chemistry letters (2008-09-09)
Benjamin Perry, Rebekah Beevers, Gavin Bennett, George Buckley, Tom Crabbe, Lewis Gowers, Lynwen James, Kerry Jenkins, Chris Lock, Verity Sabin, Sara Wright
ABSTRACT

Optimization of the cellular and pharmacological activity of a novel series of PI3 kinase inhibitors targeting multiple isoforms is described.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-Pyrazoleboronic acid pinacol ester, 97%